» Articles » PMID: 19949096

The Pleckstrin Homology Domain Adaptor Protein Bam32/DAPP1 is Required for Germinal Center Progression

Overview
Journal J Immunol
Date 2009 Dec 2
PMID 19949096
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Ab affinity maturation within germinal centers (GCs) requires weeks to complete. Several signaling pathways in B cells have been shown to be required for initiation of the GC response; however, the signaling checkpoints controlling progression and eventual dissolution of the GC reaction are poorly understood. The adaptor protein Bam32/DAPP1 was originally isolated from human GCs and functions downstream of phosphoinositide 3-kinase enzymes, which are known to have critical roles in B cell activation and GC responses. In this study we identify a unique role of Bam32/DAPP1 in promoting GC progression. Bam32-deficient mice show normal GC initiation, but premature GC dissolution after immunization with protein Ag in alum or low doses of sheep red blood cells. Adoptive transfer studies confirmed that Bam32-deficient B cells have an intrinsic impairment in the ability to mount sustained GC responses. Bam32 deficiency was also associated with impaired Ab affinity maturation. Proliferation of Bam32-deficient GC B cells was not compromised; however, these cells show impaired switch to IgG1 and increased apoptosis in situ. GCs formed by Bam32-deficient B cells contain fewer T cells, indicating that Bam32 is required for B cell-dependent T cell accumulation within established GCs. Exogenous CD40 ligand restored GC B cell numbers and switch to IgG1, indicating that Bam32-deficient B cells are competent to respond to CD40 stimulation when ligand is available. These data demonstrate that Bam32 is not required for GC initiation, but rather functions in a late checkpoint of GC progression associated with T cell recruitment and GC B cell survival.

Citing Articles

Control of germinal center B cell survival and IgE production by an adaptor molecule containing PH and SH2 domains, Aps/Sh2b2.

Iseki M, Hidano S, Kudo F, Takaki S Sci Rep. 2024; 14(1):17767.

PMID: 39090233 PMC: 11294469. DOI: 10.1038/s41598-024-68739-3.


Germinal Centre Shutdown.

Arulraj T, Binder S, Robert P, Meyer-Hermann M Front Immunol. 2021; 12:705240.

PMID: 34305944 PMC: 8293096. DOI: 10.3389/fimmu.2021.705240.


Bam32/DAPP1-Dependent Neutrophil Reactive Oxygen Species in WKYMVm-Induced Microvascular Hyperpermeability.

Hao L, Marshall A, Liu L Front Immunol. 2020; 11:1028.

PMID: 32536926 PMC: 7267069. DOI: 10.3389/fimmu.2020.01028.


Immunomodulatory nanogels overcome restricted immunity in a murine model of gut microbiome-mediated metabolic syndrome.

Mosquera M, Kim S, Zhou H, Jing T, Luna M, Guss J Sci Adv. 2019; 5(3):eaav9788.

PMID: 30944865 PMC: 6436937. DOI: 10.1126/sciadv.aav9788.


In-depth PtdIns(3,4,5)P signalosome analysis identifies DAPP1 as a negative regulator of GPVI-driven platelet function.

Durrant T, Hutchinson J, Heesom K, Anderson K, Stephens L, Hawkins P Blood Adv. 2017; 1(14):918-932.

PMID: 29242851 PMC: 5726495. DOI: 10.1182/bloodadvances.2017005173.